Cite
Ma X, Li RS, Wang J, et al. The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis. Front Pharmacol. 2016;7:70doi: 10.3389/fphar.2016.00070.
Ma, X., Li, R. S., Wang, J., Huang, Y. Q., Li, P. Y., Wang, J., Su, H. B., Wang, R. L., Zhang, Y. M., Liu, H. H., Zhang, C. E., Ma, Z. J., Wang, J. B., Zhao, Y. L., & Xiao, X. H. (2016). The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis. Frontiers in pharmacology, 770. https://doi.org/10.3389/fphar.2016.00070
Ma, Xiao, et al. "The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis." Frontiers in pharmacology vol. 7 (2016): 70. doi: https://doi.org/10.3389/fphar.2016.00070
Ma X, Li RS, Wang J, Huang YQ, Li PY, Wang J, Su HB, Wang RL, Zhang YM, Liu HH, Zhang CE, Ma ZJ, Wang JB, Zhao YL, Xiao XH. The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis. Front Pharmacol. 2016 Mar 31;7:70. doi: 10.3389/fphar.2016.00070. eCollection 2016. PMID: 27065861; PMCID: PMC4814457.
Copy
Download .nbib